Equity Overview
Price & Market Data
Price: $1.63
Daily Change: -$0.0602 / 3.69%
Range: $1.59 - $1.81
Market Cap: $2,014,791
Volume: 221,465
Performance Metrics
1 Week: -26.27%
1 Month: -57.57%
3 Months: -59.26%
6 Months: -69.54%
1 Year: -99.34%
YTD: -66.54%
Company Details
Employees: 7
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.